Axogen (AXGN) Cash & Current Investments (2010 - 2026)
Axogen's (AXGN) quarterly Cash & Current Investments came in at $101.6 million in Q1 2026, up 360.38% year-on-year from $22.1 million in Q1 2025, and up 144.66% quarter-over-quarter from $41.5 million in Q4 2025.
Axogen (AXGN) Cash & Current Investments (2010 - 2026) Analysis & Trends
Axogen's Cash & Current Investments history runs 17 years deep, the most recent figure standing at $101.6 million for Q1 2026.
- On a quarterly basis, Cash & Current Investments rose 360.38% year-over-year to $101.6 million in Q1 2026; TTM through Mar 2026 was $101.6 million, a 360.38% increase from a year earlier, with the FY2025 full-year figure at $41.5 million, up 24.03% from the prior year.
- Cash & Current Investments grew to $101.6 million in Q1 2026 per AXGN's latest filing, from $41.5 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $101.6 million in Q1 2026 and bottomed at $17.6 million in Q1 2024.
- The 5-year median for Cash & Current Investments is $34.5 million (2023), against an average of $40.6 million.
- Across the five-year window, Cash & Current Investments slumped 53.43% in 2024 and jumped 360.38% in 2026, its largest moves.
- Year by year, Cash & Current Investments stood at $48.8 million in 2022, then tumbled by 36.41% to $31.0 million in 2023, then gained by 7.92% to $33.5 million in 2024, then grew by 24.03% to $41.5 million in 2025, then soared by 144.66% to $101.6 million in 2026.
- Per Business Quant, the three latest AXGN Cash & Current Investments figures stand at $101.6 million (Q1 2026), $41.5 million (Q4 2025), and $35.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 7.30 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 3.67 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 1.12 Bn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 2.29 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | 577.00 Mn |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 3.12 Bn |
| 10 | Axogen | 2.12 Bn | 2.02 Bn | 46.19 Mn | 101.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 101.60 Mn |
| Dec 31, 2025 | 41.53 Mn |
| Sep 30, 2025 | 35.79 Mn |
| Jun 30, 2025 | 29.92 Mn |
| Mar 31, 2025 | 22.07 Mn |
| Dec 31, 2024 | 33.48 Mn |
| Sep 30, 2024 | 24.53 Mn |
| Jun 30, 2024 | 21.13 Mn |
| Mar 31, 2024 | 17.63 Mn |
| Dec 31, 2023 | 31.02 Mn |
| Sep 30, 2023 | 32.59 Mn |
| Jun 30, 2023 | 34.53 Mn |
| Mar 31, 2023 | 37.87 Mn |
| Dec 31, 2022 | 48.79 Mn |
| Sep 30, 2022 | 53.11 Mn |
| Jun 30, 2022 | 58.03 Mn |
| Mar 31, 2022 | 67.42 Mn |
| Dec 31, 2021 | 84.09 Mn |
| Sep 30, 2021 | 91.72 Mn |
| Jun 30, 2021 | 99.92 Mn |